Dexcom
DXCM
Performance
About Dexcom
Dexcom is a global medical device company specializing in continuous glucose monitoring (CGM) technology for diabetes management. It develops and markets CGM systems that provide real-time glucose readings and data to phones or receivers, enabling users to monitor glucose levels and make informed health decisions. The company has a long history in glucose biosensing and supports an ecosystem of connected partners, with products like Dexcom G7 and Stelo Glucose Biosensor, and operates worldwide from its base in San Diego, California. Since its founding in 1999, Dexcom has focused on improving diabetes care by delivering accurate, non-invasive or minimally invasive glucose monitoring solutions.
Recent News
New Study Published Evaluating PharmaSens All-in-One Insulin Patch Pump
Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration
Dexcom Unveils Next-Generation G8 CGM for Real-Time Glucose Monitoring
FDA Approves Automated Insulin Delivery System for Pregnancy
GLP-1 Microdosing May Provide More ‘Tailored Approach to Care’
Stocks Making the Biggest Moves Midday: Moderna, Instacart, Rivian Automotive, DraftKings, Coinbase & More
Elliott Investment Management Takes Stake in Dexcom, Secures Two Board Seats
Some Implied Moves for Earnings Next Week(Apr. 27th – May 1st) – 726 Companies Reporting
Apple Watch Glucose Monitoring Gets Major Breakthrough
Dexcom Unveils G8 CGM, a 50% Smaller Sensor Set for 2027 Launch
GlucoTrack Shares Jump 34% as FDA IDE Submission Looms for Implantable Glucose Monitor
Senseonics Rolls Out Eversense 365, First One‑Year CGM, Across Europe
Combining Data Can Identify High-Risk Cohorts for SDOH Initiatives
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
Alphabet Boosts Portfolio Value by $1.5 B, Adds CME Group as Top Holding
Google Unveils Screenless Fitbit Air, New Google Health App
Dexcom Seeks Expanded Medicare Coverage of CGMs for Type 2 Diabetes
US Stocks Today | Big Tech Stocks Lose Billions as AI Spending Fears Hit Valuations
Multiple CGM Sensors May Be Used with Automated Insulin Delivery
Sell in May and Go Away—Starting With These 3 Stocks
AI Nutrition Tracking Stinks
Market Quote of the Day by Sir John Templeton | “The Time of Maximum Pessimism Is the Best Time to Buy”
Recent Deals
No recent deals for this company.